Cancer Research and Treatment10.4143/crt.2013.172197047172-77Changes in the Mean Corpuscular Volume after Capecitabine Treatment Are Associated with Clinical Response and Survival in Patients with Advanced Gastric CancerHyun Ae Jung, Hyun-Jun Kim, Chi Hoon Maeng, Se Hoon Park, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang,,
Annals of Oncology10.1093/annonc/mdw335.43201627iv52Capecitabine and Regorafenib-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancerM.A. Barbera, G. Frega, A. Palloni, F. Abbati, G. Biasco, I. Garajova,,
The Breast10.1016/j.breast.2012.03.0132012214612-613Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: Is it true for capecitabine treatment or more?Cagatay Arslan, Kadri Altundag,
Journal of Clinical Pharmacy and Therapeutics10.1111/j.1365-2710.2011.01289.x2011373266-275Capecitabine for the treatment for advanced gastric cancer: efficacy, safety and ethnicityY. Ma, L. Tang, H.-X. Wang, Y.-C. Xu, Y. Ma, F.-C. Zhang,
Tumori Journal10.1177/0300891611097006062011976711-716Increased Mean Corpuscular Volume of Erythrocytes during Capecitabine Treatment: A Simple Surrogate Marker for Clinical ResponseCagatay Arslan, Sercan Aksoy, Omer Dizdar, Mevlut Kurt, Nilufer Guler, Yavuz Ozisik, Ibrahim Gullu, Kadri Altundag,
Chemotherapy10.1159/0003577712013595369-372Increased Mean Corpuscular Volume of Red Blood Cells in Patients Treated with Capecitabine for Advanced Breast and Colon CancerLaura Scarabelli, Filippo Giovanardi, Erika Gervasi, Giuseppe Prati, Debora Pezzuolo, Laura Scaltriti,
Gastric Cancer10.1007/s10120-013-0309-z2013173522-528Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer: combined analysis of the Japan Clinical Oncology Group Trials JCOG9205 and JCOG9912Atsuo Takashima, Narikazu Boku, Ken Kato, Kenichi Nakamura, Junki Mizusawa, Haruhiko Fukuda, Kuniaki Shirao, Yasuhiro Shimada, Atsushi Ohtsu,,
Cancer10.1002/cncr.253642010116204744-4752Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancerAmy Y. Chen, Stacey Fedewa, Alex Pavluck, Elizabeth M. Ward,
OncoTargets and Therapy10.2147/ott.s1878152018Volume 12269-277Should S-1 be better than capecitabine for patients with advanced gastric cancer in Asia? A systematic review and meta-analysisZiqi Ye, Jie Chen, Yuefeng Rao, Wenchao Yang,
Cancer Management and Research10.2147/cmar.s2302742020Volume 127467-7474

High Mean Corpuscular Volume as a Predictor of Poor Overall Survival in Patients with Esophageal Cancer Receiving Concurrent Chemoradiotherapy

Ke-jie Li, Wen-yue Gu, Xiao-fang Xia, Ping Zhang, Chang-lin Zou, Zheng-hua Fei,